Revealing
the attenuating mutations of F. tularensis LVS
Recombinant
Antigen-based Assays for Flavivirus Serodiagnosis
and Surveillance
Identification
and Inhibition of Cytokines Induced During
OHFV Infection
Cell
Wall Proteins in Bacillus anthracis as
Vaccines
Rational
Design and Optimization of New Live- attenuated
Vaccines for Alphaviral
Enciphalitides
Nodavirus-based
RNA Replicon Vaccines for Tick-borne
Encephalitis Virus
Antiviral
Agents as Therapy for SARS
Typhus
Group Rickettsial Antigens Recognized by CD8+
T Lymphocytes
|
Identification
and Inhibition of Cytokines Induced During OHFV Infection
Collaborating
Institution: University of Texas Medical Branch at Galveston (UTMB),
Galveston, TX
Principal
Investigator: Micheal R. Holbrook, Ph.D.
Expected
Product: Therapeutics for Omsk hemorrhagic fever virus infection
Description: Omsk hemorrhagic fever
virus (OHFV) is a tick-borne flavivirus that causes viscerotropic
disease in humans. Unlike other viscerotropic flaviviruses, such
as yellow fever virus and dengue virus, OHFV causes viscerotropic
disease in a small animal model. OHFV is closely related genetically
to other members of the tick-borne encephalitis virus (TBEV)
serocomplex, but, unlike all other members of this complex, does
not cause neurologic disease. We have previously described OHFV
infection in the Balb/c mouse where we found that viral tropism
and histopathologic changes in this model were markedly different
from infection with the neurotropic Powassan virus. Preliminary
work has also shown a disease phenotype that is distinct from
other TBEV serocomplex viruses. In this application we propose
to characterize OHFV infection in the C57BL/6 mouse model with
a fundamental examination of the host cytokine response to infection
in mouse-derived macrophages and dendritic cells and mouse tissues.
Furthermore, we also propose to examine the susceptibility of
knockout mice to OHFV infection and to examine the efficacy of
cytokine specific siRNA at limiting OHFV propagation and OHFV-induced
cytokine expression. The objective of this project is to examine
the initial host response to infection and to identify which
aspects of the host response may play a role in limiting or exacerbating
disease. We will also use cytokine specific siRNA for cell culture
studies to determine the potential therapeutic value of this
technology for limiting cytokine expression during disease. This
project will provide a significant amount of fundamental knowledge
regarding the pathogenesis of a poorly understood pathogen and
may also provide insight into the pathogenic mechanisms of other
viral hemorrhagic fevers, none of which have a good small animal
model.
|